TMA but not TMAO increases with age in rat plasma and affects smooth muscle cells viability.
It has been suggested that trimethylamine oxide (TMAO), a liver oxygenation product of gut bacteria-produced trimethylamine (TMA), is a marker of cardiovascular risk. However, mechanisms of the increase and biological effects of TMAO are obscure. Furthermore, the potential role of TMAO precursor, i.e. TMA has not been investigated. We evaluated the effect of age, a cardiovascular risk factor, on plasma levels of TMA and TMAO, gut bacteria composition, gut-to-blood penetration of TMA, histological and hemodynamic parameters in 3-month-old and 18-month-old, male, Sprague-Dawley and Wistar-Kyoto rats. Cytotoxicity of TMA and TMAO was studied in human vascular smooth muscle cells (hVSMCs). Older rats showed significantly different gut bacteria composition, a significantly higher guttoblood TMA penetration, and morphological and hemodynamic alterations in intestines. In vitro, TMA at concentration of 500 µmol/L (2-fold higher than in portal blood) decreased hVSMCs viability. In contrast, TMAO at 1000-fold higher concentration than physiological one, had no effect on hVSMCs viability. In conclusion, older rats show higher plasma level of TMA due to a "leaky gut". TMA but not TMAO affects hVSMCs viability. We propose that TMA but not TMAO may be a marker and mediator of cardiovascular risk.